By Counterforce Health Team in Gilenya (fingolimod) —

How to Get Gilenya (Fingolimod) Covered by Aetna (CVS Health) in Texas: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Gilenya (Fingolimod) Covered by Aetna (CVS Health) in Texas

Aetna requires prior authorization for Gilenya (fingolimod) with documentation of relapsing MS diagnosis, baseline safety tests (EKG, eye exam), and often proof of trying preferred first-line therapies. Your neurologist submits the PA via Aetna's provider portal or CVS Caremark's system. If denied, Texas law gives you 180 days to file an internal appeal, then 4 months for external review through a Texas Independent Review Organization (IRO). First step today: Call the number on your Aetna card to confirm PA status and ask for the specific formulary tier for Gilenya vs. generic fingolimod.

Table of Contents

  1. Coverage Basics: Is Gilenya Covered by Aetna?
  2. Prior Authorization Process: Who Submits and How
  3. Timing and Deadlines: How Long Does Approval Take?
  4. Clinical Criteria: What Aetna Requires for Approval
  5. Costs and Copay Assistance Options
  6. Denial Appeals: Texas Internal and External Review
  7. Annual Renewals: Reauthorization Requirements
  8. Specialty Pharmacy: CVS Specialty Requirements
  9. Common Problems and Solutions
  10. Frequently Asked Questions

Coverage Basics: Is Gilenya Covered by Aetna?

Yes, but with conditions. Aetna covers both brand Gilenya and generic fingolimod under their pharmacy benefit, but placement varies by plan:

  • Generic fingolimod: Usually preferred on formulary with lower cost-sharing
  • Brand Gilenya: Often non-preferred or requires formulary exception
  • Specialty tier: Both versions typically require CVS Specialty pharmacy
  • Prior authorization: Required for all fingolimod products
Note: Your specific plan's formulary determines exact coverage. Check your 2024/2025 drug guide or call the member services number on your Aetna card.

Coverage at a Glance

Requirement What It Means Where to Find It
Prior Authorization Doctor must get approval before filling Aetna PA requirements
Specialty Pharmacy Must fill at CVS Specialty CVS Caremark member portal
Step Therapy May need to try preferred DMTs first Plan-specific formulary
Age Requirement Generally 10+ years for relapsing MS FDA labeling requirements
Neurologist Prescribing Often required or preferred Aetna medical policies

Prior Authorization Process: Who Submits and How

Step-by-Step: Fastest Path to Approval

  1. Confirm Coverage (Patient/Clinic Staff)
    • Call Aetna member services: number on your ID card
    • Ask: "Is Gilenya or generic fingolimod covered? What's my copay? Is PA required?"
    • Expected timeline: 5-10 minutes
  2. Gather Required Documentation (Clinic)
    • MS diagnosis with ICD-10 codes
    • Prior DMT trials and outcomes
    • Baseline safety labs (see criteria section)
    • Expected timeline: 1-2 days
  3. Submit PA Request (Prescriber)
  4. Follow Up (Clinic/Patient)
    • Check status after 3-5 business days
    • Request expedited review if urgent
    • Expected timeline: 30-45 days for standard review

Required Submission Documents

  • Completed PA form with prescriber signature
  • Chart notes confirming relapsing MS diagnosis
  • Documentation of prior therapy trials/failures
  • Baseline EKG results and cardiac clearance
  • Ophthalmology exam report (macular assessment)
  • Laboratory results (CBC, liver function tests)
  • Vaccination records (especially varicella-zoster)

Timing and Deadlines: How Long Does Approval Take?

Standard Review Timeline

  • Aetna decision: 30-45 business days from complete submission
  • Incomplete submissions: Additional 15-30 days for missing information
  • CVS Specialty setup: 3-5 business days after approval

Expedited Review (When Available)

  • Qualifying situations: Delay could seriously jeopardize health or function
  • Decision time: 72 hours for urgent pre-service requests
  • How to request: Mark PA form "URGENT" and provide clinical justification
Tip: Submit PA requests at least 2 weeks before you need to start treatment to avoid delays.

Clinical Criteria: What Aetna Requires for Approval

Medical Necessity Requirements

Based on Aetna's published criteria, approval requires:

  • Diagnosis: Relapsing forms of multiple sclerosis (clinically isolated syndrome, relapsing-remitting, or secondary progressive with relapses)
  • Age: 10 years or older
  • Prescriber: Neurologist or MS specialist involvement
  • Prior therapy: Documentation of inadequate response, intolerance, or contraindication to preferred first-line DMTs

Safety Monitoring Requirements

Cardiac Evaluation:

  • Baseline EKG showing no significant conduction abnormalities
  • Plan for first-dose 6-hour monitoring with hourly vitals and post-dose EKG
  • Cardiology clearance if high-risk cardiac history

Ophthalmologic Assessment:

  • Baseline macular examination before initiation
  • Follow-up exam planned at 3-4 months
  • Additional monitoring for diabetes or uveitis history

Laboratory Work-Up:

  • Complete blood count with differential
  • Liver function tests (ALT, AST, bilirubin)
  • Varicella-zoster virus immunity confirmation
  • Pregnancy test if applicable

Clinician Corner: Medical Necessity Letter Checklist

Your neurologist's letter should include:

✓ Problem statement: Specific MS subtype and relapse history
✓ Prior treatments: Names, dates, outcomes, and reasons for discontinuation
✓ Clinical rationale: Why fingolimod is appropriate now
✓ Safety plan: Monitoring protocols in place
✓ Guidelines support: Reference to FDA labeling and MS society recommendations

Costs and Copay Assistance Options

Insurance Cost-Sharing

  • Specialty tier copay: Typically $150-$350 per month
  • Coinsurance: 20-40% of drug cost (can be $2,000+ monthly)
  • Annual out-of-pocket maximum: Varies by plan ($3,000-$9,000+ typical range)

Manufacturer Copay Assistance

Gilenya Go Program (Brand Gilenya):

  • Up to $18,000 per year in copay assistance
  • May reduce monthly cost to $0
  • Commercial insurance only (not Medicare/Medicaid)
  • Enrollment: Call 1-800-445-3692

Generic Fingolimod Programs:

Additional Financial Resources

Important: Check if your Aetna plan uses copay accumulators or maximizers, which can limit the effectiveness of manufacturer assistance.

Denial Appeals: Texas Internal and External Review

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
"Not medically necessary" Medical necessity appeal with specialist letter Updated chart notes, relapse history, MRI results
"Step therapy required" Document prior DMT failures/intolerance Detailed treatment history, adverse event records
"Missing safety monitoring" Submit complete monitoring plan EKG, eye exam, lab results
"Non-formulary" Request formulary exception Clinical justification for brand vs. generic

Texas Appeals Process

Internal Appeal (Required First Step):

  • Deadline: 180 days from denial
  • Decision time: 45 business days (72 hours if expedited)
  • How to file: Written request to Aetna with supporting documentation

External Review (Texas IRO):

  • When available: After final internal denial
  • Deadline: 4 months from final denial
  • Decision time: 20 days standard, 8 days expedited
  • Cost: Free to patient (Aetna pays IRO fees)
  • Binding: Yes, Aetna must comply if overturned

How to Request Texas IRO External Review

  1. Complete IRO request form (included with final denial letter)
  2. Attach all documentation: Denial letters, medical records, specialist statements
  3. Mark expedited if urgent: Include statement that delay will jeopardize health
  4. Submit per instructions: Usually fax or mail as specified in denial packet
For help: Call Texas Department of Insurance at 1-800-252-3439

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed rebuttals. Their platform helps patients and clinicians navigate complex prior authorization requirements and appeal processes for specialty medications like Gilenya, ensuring all procedural requirements are met while building the strongest possible case for coverage.

Annual Renewals: Reauthorization Requirements

When to Reauthorize

  • Approval period: Typically 12 months
  • Timing: Submit renewal 30-45 days before expiration
  • Automatic renewal: Not standard; requires new PA submission

Renewal Documentation Requirements

Based on Aetna's continuation criteria:

  • Clinical response: Evidence of disease stability or improvement
  • Neurologist confirmation: Ongoing specialist involvement
  • Safety monitoring: Updated lab results, no significant adverse events
  • Compliance: Documentation of medication adherence

Evidence of Treatment Success

  • Fewer or no new relapses since starting therapy
  • Stable or improved EDSS (disability) scores
  • MRI showing no new or enlarging lesions
  • Maintained functional status

Specialty Pharmacy: CVS Specialty Requirements

Why CVS Specialty is Required

Aetna contracts with CVS Specialty as their primary specialty pharmacy for oral MS medications. This ensures:

  • Proper cold-chain storage and handling
  • Clinical monitoring and adherence support
  • Coordination with copay assistance programs
  • Insurance claim processing expertise

Setting Up CVS Specialty

  1. Transfer notification: CVS Specialty will contact you after PA approval
  2. Enrollment call: Confirm shipping address and preferences
  3. First shipment: Usually 3-5 business days after enrollment
  4. Ongoing refills: Automatic unless you request changes

CVS Specialty Contact Information

  • Patient services: 1-800-237-2767
  • Prescriber line: 1-800-237-2767
  • Hours: Monday-Friday 8 AM-8 PM ET, Saturday 9 AM-5 PM ET

Common Problems and Solutions

PA Portal Issues

Problem: Electronic submission system down
Solution: Fax PA to CVS Caremark backup number (check current fax on member ID card)

Missing Forms

Problem: Can't find current PA form
Solution: Download from CVS Caremark provider resources

Delayed Decisions

Problem: No response after 45 days
Solution: Call Aetna provider services to request status update and escalation

Coverage Disputes

Problem: Plan says drug isn't covered
Solution: Request formulary exception with medical necessity documentation

For complex appeals or when facing repeated denials, Counterforce Health can help analyze your specific situation and develop a targeted strategy that addresses Aetna's exact denial reasons while incorporating Texas-specific appeal procedures.

Frequently Asked Questions

How long does Aetna PA take for Gilenya in Texas?
Standard review takes 30-45 business days. Expedited review (for urgent cases) is decided within 72 hours.

What if brand Gilenya is non-formulary?
Request a formulary exception with documentation that generic fingolimod is inappropriate due to medical necessity, previous failure, or intolerance.

Can I request expedited appeal in Texas?
Yes, if delay could seriously jeopardize your health or ability to regain maximum function. Both internal and external reviews can be expedited.

Does step therapy apply if I've used Gilenya before?
Generally no - if you've received the drug in the past 365 days, step therapy requirements are typically waived.

What if I can't afford the copay even with assistance?
Apply for grants from HealthWell Foundation, PAN Foundation, or contact the National MS Society for additional resources.

How do I know if my plan is subject to Texas IRO rules?
Texas-regulated commercial plans follow state IRO rules. Self-funded employer plans and federal programs (Medicare, some ERISA plans) may follow different procedures.

What happens if CVS Specialty can't fill my prescription?
Contact Aetna member services to request an exception for an alternative specialty pharmacy, providing documentation of the access issue.

Can my neurologist request a peer-to-peer review?
Yes, prescribers can request to speak directly with Aetna's medical director to discuss the case before or during the appeal process.

Disclaimer: This information is for educational purposes only and is not medical advice. Always consult with your healthcare provider about treatment decisions. Insurance coverage varies by plan and individual circumstances.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.